Amicus Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
FOLD Nasdaq 2836 amicusrx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amicus Therapeutics, Inc.

Bet on These 4 Top-Performing Liquid Stocks to Maximize Returns - Nov 7th, 2025 8:40 am
Catalyst Pharmaceuticals Q3 Earnings Beat, Firdapse Revenues Rise Y/Y - Nov 6th, 2025 8:43 am
Viatris Tops Q3 Earnings & Revenue Estimates, Ups '25 Guidance - Nov 6th, 2025 8:24 am
RXRX Q3 Loss Narrower Than Expected, Revenues Decline Y/Y - Nov 6th, 2025 7:24 am
ADMA's Q3 Earnings Match Estimates, Revenues Beat on Strong Asceniv Sales - Nov 6th, 2025 6:27 am
Amicus Therapeutics (FOLD): Profitable Growth Forecasts Challenge Market’s Discounted Valuation - Nov 5th, 2025 6:19 pm
The Bull Case For Amicus Therapeutics (FOLD) Could Change Following First GAAP Profit and 17% Revenue Jump - Nov 5th, 2025 11:13 am
Ultragenyx Q3 Earnings and Sales Miss Estimates, Increase Y/Y - Nov 5th, 2025 8:48 am
Madrigal Q3 Earnings Miss, MASH Drug Sales Drive Top Line, Stock Up - Nov 5th, 2025 8:41 am
Amicus' Q3 Earnings Beat, Higher Product Sales Drive Y/Y Revenues - Nov 5th, 2025 8:08 am
Compared to Estimates, Amicus Therapeutics (FOLD) Q3 Earnings: A Look at Key Metrics - Nov 5th, 2025 7:30 am
Amicus Therapeutics Inc (FOLD) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... - Nov 4th, 2025 2:07 pm
Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus - Nov 4th, 2025 7:54 am
Amicus Therapeutics (FOLD) Beats Q3 Earnings and Revenue Estimates - Nov 4th, 2025 6:35 am
Amicus Therapeutics: Q3 Earnings Snapshot - Nov 4th, 2025 5:29 am
Amicus Therapeutics Announces Third Quarter 2025 Financial Results and Corporate Updates - Nov 4th, 2025 5:00 am
Apellis Stock Down Despite Q3 Earnings and Revenues Beat Estimates - Oct 31st, 2025 11:45 am
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025 - Oct 31st, 2025 5:00 am
A Fresh Look at Amicus Therapeutics (FOLD) Valuation Following Recent Share Price Momentum - Oct 25th, 2025 11:09 am
Assessing Amicus Therapeutics After a 7.8% Rally and Growing Pipeline Optimism - Oct 25th, 2025 3:07 am